Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($0.62), $0.06 worse than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.